Cite
HARVARD Citation
Armenia, D. et al. (2021). Virological response and resistance profile in highly treatment‐experienced HIV‐1‐infected patients switching to dolutegravir plus boosted darunavir in clinical practice. HIV medicine. 22 (6), pp. 519-525. [Online].